U.S. Biotech Stock News

Wondering if Hims & Hers Health at around US$30.56 is offering real value or just riding a wave of enthusiasm? This article breaks down what the current price may be implying about the business. The stock has posted returns of 6.0% over the last week and 46.6% over the past month, set against a negative 8.5% return year to date and a 163.7% return over three years. Recent news coverage has focused on Hims & Hers Health as a fast growing telehealth brand, with attention on its direct to...

Olin (OLN) is drawing attention after recent trading left the stock at US$26.77, with returns mixed across different periods, including a decline over the past month and gains over the past 3 months and year to date. See our latest analysis for Olin. Recent trading suggests short term share price momentum has cooled, with a 30 day share price return decline of 4.53%, even though the year to date share price return and 1 year total shareholder return remain positive. If Olin has you...

Gilead Sciences chose not to extend certain early stage pipeline options within its Arcus Biosciences collaboration. The decision lets specific option rights expire instead of making an option continuation payment. This move narrows Gilead's external early pipeline exposure in oncology and immunology while it reallocates capital across its broader oncology efforts. For investors following NasdaqGS:GILD, this shift comes as the shares trade around $130.4, with a 1 year return of 29.8% and a...

If you are wondering whether Masimo at around US$178.63 is offering value or stretching expectations, you are not alone. The stock has been relatively steady in the very short term, with returns of 0.1% over 7 days and 0.3% over 30 days. The year to date return of 40.2% and 1 year return of 9.1% contrast with 3 year and 5 year returns of negative 5.6% and negative 23.2%. Recent coverage has focused on Masimo's share price recovery and the debate over what is already reflected in the current...

TD SYNNEX (SNX) is back in focus after expanding its AI Infrastructure-as-a-Service offering with dedicated NVIDIA HGX B300 clusters on Nebius AI Cloud, while adding fresh partnerships in email, privacy, and cloud security. See our latest analysis for TD SYNNEX. The recent AI infrastructure rollout and new security and privacy partnerships have coincided with a sharp pick up in momentum, with a 30 day share price return of 39.04% and a 1 year total shareholder return of 107.38%. If TD...

Saia overview and recent performance Saia (SAIA) has attracted attention after recent share price moves, with the stock last closing at $442.44. Over the past month and past 3 months, total returns stand at 28.48% and 25.94%. See our latest analysis for Saia. That recent surge in momentum sits on top of a 31.22% year to date share price return and an 80.12% 1 year total shareholder return, hinting at shifting expectations around Saia’s growth and risk profile. If Saia’s move has you looking...

West Pharmaceutical Services (WST) has drawn attention after a recent 1-day share price decline of about 1%, set against a gain of nearly 24% over the past month and a return of around 29% over the past three months. See our latest analysis for West Pharmaceutical Services. The recent 1-day share price decline sits alongside strong short-term momentum, with a 7-day share price return of 11.85% and a 1-year total shareholder return of 43.20%. However, 3 and 5-year total shareholder returns are...

What recent returns say about First Solar today First Solar (FSLR) has had a mixed run, with the share price showing a 4.3% gain over the past month but a 20.0% decline over the past 3 months, leaving year to date performance weaker. For longer term holders, the total return figures are different again, with 1 year, 3 year and 5 year total returns of 36.6%, 6.1% and 153.2% respectively, which may shape how you think about your own holding period. See our latest analysis for First Solar. The...

Chewy (NYSE:CHWY) has entered a definitive agreement to acquire Modern Animal, a technology-focused veterinary care platform. The deal adds Modern Animal’s membership-based clinic network to Chewy’s existing pharmacy and commerce operations. The acquisition expands Chewy’s vet care footprint from 18 to 47 locations, deepening its presence in pet healthcare services. Chewy’s move toward integrated veterinary care comes with the stock trading at $26.02 and returns that have been under...

Dingdong (Cayman) (NYSE:DDL) has wrapped up FY 2025 with fourth quarter revenue of C¥6.2b and basic EPS of C¥0.14, capping a year in which trailing twelve month EPS reached C¥1.32 on revenue of C¥24.0b. Over the past six quarters, the company has seen quarterly revenue move from C¥20.8b to C¥24.0b on a trailing basis, while quarterly basic EPS has ranged from C¥0.04 to C¥0.61. This gives investors a clear view of both scale and earnings progression. With earnings up 43.3% over the past year...

Old Dominion Freight Line recently drew investor attention after a series of reports highlighted its history of earnings surprises and the potential for another beat in the now‑completed April 29 earnings release. This renewed focus comes despite earlier concerns about softer long‑term revenue trends, declining earnings per share, and weaker returns on invested capital, underscoring the importance of near‑term earnings momentum. With expectations centered on another possible earnings beat,...

United Airlines Holdings, NasdaqGS:UAL, is introducing new cargo surcharges and pricing changes starting May 1. The new market disruption fee is aimed at offsetting higher jet fuel costs and geopolitical risks impacting operations. The move follows a reported decline in cargo revenue despite growth in the wider global cargo market. United Airlines Holdings, NasdaqGS:UAL, is trading at $93.0, with the share price up 36.4% over the past year and 112.3% over three years. The stock has seen a...

Why Blackstone’s latest quarter has investors paying attention Blackstone (BX) just posted first quarter results that topped Wall Street forecasts, with distributable earnings up 25% year over year and assets under management above US$1.3 trillion, drawing fresh attention to the stock. Management highlighted strong inflows, an increasing tilt toward AI related data centers and energy infrastructure, and plans for a separate public company focused on stabilized data centers, even as private...

If you are wondering whether C.H. Robinson Worldwide is still good value after a strong run, this article walks through what the current share price might be implying about the business. The stock last closed at US$183.03, with returns of 0.4% over 7 days, 7.8% over 30 days, 11.8% year to date, 107.8% over 1 year, 95.1% over 3 years, and 111.8% over 5 years. This performance raises fresh questions about what is already priced in. Recent coverage has focused on C.H. Robinson Worldwide as an...

In recent years, Expand Energy (formerly Chesapeake Energy) has emerged from bankruptcy, rebranded, and continued producing natural gas, oil, and natural gas liquids across several U.S. shale basins. Since this overhaul, the company has delivered sustained annual revenue growth of 20.3% and a 23.6 percentage-point improvement in EBITDA margin, highlighting a substantial uplift in operational efficiency and scale. Next, we’ll examine how this sustained revenue and margin improvement reshapes...

Wondering if Baxter International at around US$18.16 is a bargain or a value trap? This article breaks down what that price really implies for you. The stock has been choppy, with a 6.1% return over 30 days and returns of 2.9% over 7 days, 6.9% year to date, 39.1% over 1 year, 59.2% over 3 years, and 76.5% over 5 years. Recent share price moves come against a backdrop of ongoing scrutiny of medical equipment companies and how investors view their long term prospects. For Baxter, that context...

Encore Capital Group recently reported a strong fourth quarter, with revenue rising at the fastest pace among specialty finance peers and results surpassing analyst expectations, underscoring solid operational execution and industry leadership. This performance highlights how Encore’s ability to convert favorable market conditions into outsized revenue growth may be reinforcing perceptions of its competitive positioning within specialty finance. Against this backdrop of...

American Express (AXP) has just opened Q1 2026 earnings season with a recent run of quarterly numbers that saw revenue move from US$15.3 billion in Q3 2024 to US$17.6 billion in Q4 2025, while basic EPS shifted from US$3.49 to US$3.54 over the same stretch. Over the last twelve months to Q4 2025, trailing revenue reached US$67.0 billion with basic EPS of US$15.40, giving investors a view of how the top and bottom lines are tracking into the new year and outlining expectations around the...

Live Oak Bancshares (LOB) is back in focus after its first quarter update, as higher earnings per share, stronger net interest income, and meaningful growth in adjusted pre provision net revenue drew investor attention. See our latest analysis for Live Oak Bancshares. The latest move in the shares has been relatively steady, with a 14.05% 1 month share price return and a 7.84% year to date share price return. The 1 year total shareholder return of 41.28% points to momentum that has been...

Princeton Bancorp (BPRN) just opened 2026 with Q1 results that put the focus squarely on earnings power, posting total revenue of US$21.5 million and basic EPS of US$0.92, underpinned by net income of US$6.2 million. Over the last year, the company has seen revenue across the trailing twelve months sit at US$78.4 million and basic EPS at US$2.86. This gives you a clearer sense of how this quarter fits into the broader run rate. With net profit margins over the past year running ahead of the...

BayCom (BCML) has kicked off 2026 with Q1 results framed by recent quarterly momentum, with Q4 2025 revenue at US$25.6 million, basic EPS of about US$0.63 and net income excluding extra items of US$6.9 million, against trailing 12 month revenue of roughly US$96.5 million and EPS of about US$2.18 through the same period. Over the past year, revenue has moved between US$94.9 million and US$96.6 million on a trailing 12 month basis, while EPS has stayed in a tight band around US$2.10 to US$2.18...

For investors considering whether Darling Ingredients at around US$60 a share still offers value or whether most of the upside is already reflected in the price, this article focuses squarely on what the current price implies. The stock recently closed at US$60.18, with returns of 3.8% over 7 days, 2.3% over 30 days, 59.9% year to date and 88.8% over the last year. These figures have understandably led investors to ask what is already baked into the valuation. Recent coverage has highlighted...

QXO (NYSE:QXO) has become a national sponsor of the National Hispanic Contractors Association to support Latino contractors across the US. The sponsorship focuses on expanding education, resources, and business opportunities for Latino professionals in construction and building products. This move extends QXO's activity beyond M&A and targets broader community engagement and industry inclusion. QXO, trading at $20.97, has seen a 62.8% return over the past year, with a 6.3% return year to...

In April 2026, Rubrik announced Rubrik Agent Cloud for Google’s Gemini Enterprise Agent Platform and new Google Cloud SQL cyber resilience capabilities, bringing AI agent governance and immutable, automated backups for managed PostgreSQL databases into its Security Cloud offering. Together, these launches extend Rubrik deeper into Google Cloud’s AI and database ecosystems, tying its data security platform to customers’ mission-critical workloads and emerging autonomous agent...